Frankfurt - Delayed Quote EUR
Tandem Diabetes Care, Inc. (TD5A.F)
15.24
-0.49
(-3.08%)
As of 8:01:16 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
940,203
940,203
747,718
801,217
702,799
Cost of Revenue
450,629
450,629
380,028
388,231
326,584
Gross Profit
489,574
489,574
367,690
412,986
376,215
Operating Expense
588,701
588,701
600,920
505,834
353,562
Operating Income
-99,127
-99,127
-233,230
-92,848
22,653
Net Non Operating Interest Income Expense
10,578
10,578
12,976
-152
-5,366
Other Income Expense
-3,321
-3,321
-78,750
147
-1,386
Pretax Income
-91,870
-91,870
-220,254
-92,852
15,901
Tax Provision
4,155
4,155
2,357
1,742
335
Net Income Common Stockholders
-96,025
-96,025
-222,611
-94,594
15,566
Diluted NI Available to Com Stockholders
-96,025
-96,025
-222,611
-94,594
15,566
Basic EPS
-1.47
--
-3.43
-1.47
0.25
Diluted EPS
-1.47
--
-3.43
-1.47
0.24
Basic Average Shares
65,451
--
64,969
64,146
63,000
Diluted Average Shares
65,451
--
64,969
64,146
64,349
Total Operating Income as Reported
-99,127
-99,127
-233,230
-92,848
22,653
Total Expenses
1,039,330
1,039,330
980,948
894,065
680,146
Net Income from Continuing & Discontinued Operation
-96,025
-96,025
-222,611
-94,594
15,566
Normalized Income
-95,023.28
-95,023.28
-222,611
-94,710.13
16,922.80
Interest Income
17,993
17,993
22,858
6,057
674
Interest Expense
5,509
5,509
8,079
4,313
4,313
Net Interest Income
10,578
10,578
12,976
-152
-5,366
EBIT
-86,361
-86,361
-212,175
-88,539
20,214
EBITDA
-69,754
-69,754
-196,460
-74,209
34,059
Reconciled Cost of Revenue
450,629
450,629
380,028
388,231
326,584
Reconciled Depreciation
16,607
16,607
15,715
14,330
13,845
Net Income from Continuing Operation Net Minority Interest
-96,025
-96,025
-222,611
-94,594
15,566
Total Unusual Items Excluding Goodwill
-1,268
-1,268
--
147
-1,386
Total Unusual Items
-1,268
-1,268
--
147
-1,386
Normalized EBITDA
-68,486
-68,486
-196,460
-74,356
35,445
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-266.28
-266.28
--
30.87
-29.20
12/31/2021 - 11/22/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade